Study S002363

The Effects of a GLP-1R Agonist (the Drug Wegovy®) on Body Composition and Performance in Military Personnel

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06468748
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: WITHDRAWN
Enrollment: 0
Start: 2024-08-01
Primary completion: 2025-03-27
Lead sponsor: United States Army Research Institute of Environmental Medicine
Conditions: Obesity
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Weight Loss [24 weeks]
Body composition [24 weeks]
Physical Performance [24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.